NCT06315478View on ClinicalTrials.gov

Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

March 16, 2021

Study Completion Date

November 1, 2021

Conditions
H.Pylori Infection
Interventions
DRUG

Omeprazole 20 MG Oral Tablet

standard triple therapy for 14 days Bid for each drug

DRUG

Amoxicillin 500Mg Tab

Quadruple regimen for 14 days Bid for each drug

DRUG

Clarithromycin 500Mg Tab

Hybrid regimen, PPI and Amoxicillin for first 7 days then adding clarithromycin and metronidazole for the second 7 days

Trial Locations (1)

Unknown

Badr hospital, Cairo

All Listed Sponsors
lead

Helwan University

OTHER

NCT06315478 - Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians | Biotech Hunter | Biotech Hunter